Oracle Buys Intellectual Property Assets of Conformia
Redwood Shores, CA – June 17, 2009
Today Oracle announced that it has acquired the intellectual property assets of Conformia Software.
Conformia’s Product and Process Lifecycle Management (PPLM) software has unique capabilities for Life Sciences companies to manage drug design, development and transfer to production across Bio, Pharmaceutical and Chemical drug components.
Oracle plans to integrate Conformia’s product and technology into Oracle Agile PLM solution to offer an end-to-end solution for managing drug development, packaging and commercialization.
Oracle plans to provide integrations to Oracle applications, Oracle Health Sciences applications and 3rd party systems.
This combination will enable Pharmaceutical and Bio-technology companies to accelerate innovation, meet regulatory objectives and improve productivity.
Financial details of the transaction were not disclosed.
"The addition of Conformia Software technology underscores Oracle’s commitment to provide customers with a differentiated, out-of-box industry-based solution," said Oracle Vice President of PLM Strategy Hardeep Gulati. "Oracle’s PLM offering will give our Life Sciences industry customers a complete solution to manage drug design, development to commercialization."